Scarica l'app Stockscreener
99.66
0.81%
-0.87
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$100.53
Aprire:
$99.83
Volume 24 ore:
1.76M
Relative Volume:
0.22
Capitalizzazione di mercato:
$147.70B
Reddito:
$18.49B
Utile/perdita netta:
$2.50B
Rapporto P/E:
59.32
EPS:
1.6801
Flusso di cassa netto:
$3.49B
1 W Prestazione:
+3.62%
1M Prestazione:
+1.93%
6M Prestazione:
+6.56%
1 anno Prestazione:
+13.25%
Intervallo 1D:
$99.29
$100.33
Intervallo di 1 settimana:
$95.59
$101.02
Portata 52W:
$80.64
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Nome
Boston Scientific Corp
Settore
Industria
Telefono
508-683-4000
Indirizzo
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Confronta BSX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
99.68 | 148.96B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
ABT
Abbott Laboratories
|
128.55 | 225.41B | 43.84B | 13.94B | 6.78B | 7.9979 |
|
SYK
Stryker Corp
|
378.67 | 145.74B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.83 | 123.04B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
75.69 | 44.20B | 5.69B | 1.41B | 577.90M | 6.9828 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-03 | Downgrade | Erste Group | Buy → Hold |
| 2025-09-08 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-06-16 | Iniziato | Leerink Partners | Outperform |
| 2025-04-16 | Aggiornamento | Needham | Hold → Buy |
| 2025-01-10 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Downgrade | Needham | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2024-02-01 | Aggiornamento | Mizuho | Neutral → Buy |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-06-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2022-12-22 | Iniziato | Mizuho | Neutral |
| 2022-12-20 | Ripresa | Citigroup | Buy |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-06 | Iniziato | Wolfe Research | Outperform |
| 2022-05-27 | Aggiornamento | Needham | Hold → Buy |
| 2022-04-13 | Ripresa | Truist | Buy |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-05-26 | Downgrade | Needham | Buy → Hold |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-17 | Iniziato | Truist | Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-04-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Neutral |
| 2020-02-06 | Ripresa | BTIG Research | Buy |
| 2019-12-30 | Reiterato | Cowen | Outperform |
| 2019-12-19 | Downgrade | Needham | Strong Buy → Buy |
| 2019-09-05 | Ripresa | JP Morgan | Overweight |
| 2019-09-03 | Ripresa | Barclays | Overweight |
| 2019-05-13 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Iniziato | UBS | Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-10-02 | Reiterato | Morgan Stanley | Overweight |
| 2018-09-07 | Reiterato | Needham | Strong Buy |
| 2018-09-04 | Aggiornamento | Jefferies | Hold → Buy |
| 2018-07-06 | Reiterato | Needham | Strong Buy |
| 2018-06-27 | Iniziato | Bernstein | Outperform |
| 2018-04-26 | Reiterato | Needham | Strong Buy |
Mostra tutto
Boston Scientific Corp Borsa (BSX) Ultime notizie
Boston Scientific (BSX) Receives a Buy from Truist Financial - The Globe and Mail
Analyst Visit Confirms Growth Potential for Boston Scientific Corporation (BSX), Buy Rating Retained - Insider Monkey
Chart based analysis of Boston Scientific Corporation trendsEarnings Miss & Daily Volume Surge Trade Alerts - newser.com
Risk vs reward if holding onto Boston Scientific CorporationJuly 2025 Outlook & Short-Term Trading Alerts - newser.com
Can Boston Scientific Corporation stock sustain revenue momentumTrade Volume Report & Free Technical Confirmation Trade Alerts - newser.com
Boston Scientific (BSX) Reports Q3: Everything You Need To Know Ahead Of Earnings - The Globe and Mail
What market sentiment indicators show for Boston Scientific Corporation stockWeekly Profit Report & Fast Moving Stock Watchlists - newser.com
Boston Scientific Corp. Stock Outperforms Competitors On Strong Trading Day - 富途牛牛
Boston Scientific continues acquisition spree with $533M deal - The Business Journals
Boston Scientific Corp (BSX)'s Winning Formula: Financial Metrics and Competitive Strengths - GuruFocus
What Fibonacci levels say about Boston Scientific Corporation rebound2025 Volatility Report & Weekly Top Gainers Trade List - newser.com
Boston Scientific To Acquire Privately-Held Pain Solutions Developer Nalu Medical For About $533M - Stocktwits
Boston Scientific Corp (BSX.HM) latest press releases and corporate news - Yahoo
Published on: 2025-10-18 08:40:56 - nchmf.gov.vn
Boston Scientific (BSX): Assessing Valuation as Shares Post Steady Gains - Yahoo
Weekly Trades: Why Boston Scientific Corporation stock remains undervaluedEarnings Growth Report & Daily Price Action Insights - nchmf.gov.vn
Boston Scientific expands chronic pain portfolio, buys Nalu for $533M - BioWorld MedTech
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific Buying Rest Of Pain Therapy Biz For $533M - Law360
Boston Scientific to acquire Nalu Medical for $533M - MassDevice
Boston Scientific Dives Into Chronic Pain Through New Acquisition - Medical Device and Diagnostic industry
Boston Scientific acquires Nalu Medical for $533m - Yahoo Finance
Boston Scientific to purchase California medtech for $533M - Worcester Business Journal
Boston Scientific To Acquire Nalu Medical In $600 Million Pain Relief Deal - Sahm
Boston Scientific To Acquire Nalu Medical In $600 Million Pain Relief Deal - Benzinga
Needham Reiterates Buy Rating for Boston Scientific (BSX) at $12 - GuruFocus
Boston Scientific boosts chronic pain therapy portfolio with Nalu deal - Reuters
Unlocking Q3 Potential of Boston Scientific (BSX): Exploring Wall Street Estimates for Key Metrics - Yahoo Finance
Boston Scientific to acquire Nalu Medical for $533 million - Investing.com
Boston Scientific (BSX) to Acquire Nalu Medical in Strategic Mov - GuruFocus
Boston Scientific boosts chronic pain therapy portfolio with Nalu deal By Reuters - Investing.com
Boston Scientific to buy Nalu Medical for $533M - Yahoo Finance
Boston Scientific Announces Agreement To Acquire Nalu Medical, Inc. - Barchart.com
Comparing Boston Scientific Corporation in custom built stock radarsJuly 2025 Highlights & Daily Stock Trend Watchlist - newser.com
Boston Scientific Corp (BSX.HM) latest stock news and headlines - Yahoo
Boston Scientific Corp (BSX.HM) Latest Press Releases & Corporate News - Yahoo
Boston Scientific (BSX) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Boston Scientific Corp (BSX.HM) Stock Price, News, Quote & History - Yahoo
Why Boston Scientific Corporation stock remains on watchlistsJuly 2025 News Drivers & AI Powered Market Entry Ideas - newser.com
Boston Scientific Corp (BSX.HM) interactive stock chart - Yahoo
Boston Scientific Corp (BSX.HM) stock major holders - Yahoo
Boston Scientific Corp (BSX.HM) analyst ratings, estimates and forecasts - Yahoo
Boston Scientific Corp (BSX.HM) Company Profile & Facts - Yahoo
What Makes Boston Scientific Corporation (BSX) an Investment Choice? - Yahoo Finance
Is Boston Scientific’s Share Price Justified After Its Recent 7.6% Monthly Drop in 2025? - Yahoo Finance
Boston Scientific Corp (BSX.HM) Analyst Ratings, Estimates & Forecasts - Yahoo
Boston Scientific Corp (BSX.HM) company profile and facts - Yahoo
Boston Scientific Corp (BSX.HM) Income Statement - Yahoo
Boston Scientific Corp (BSX.HM) stock historical prices and data - Yahoo
Boston Scientific Corp (BSX.HM) insider ownership and holdings - Yahoo
OFI Invest Asset Management Has $1.38 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp Azioni (BSX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
0.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):